MEDULLOBLASTOMA RECURRENT

MEDULLOBLASTOMA RECURRENT was reported 113 times

MEDULLOBLASTOMA RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Recombinant Human Growth Hormone [EPC] 16 0.0007
1 Topoisomerase Inhibitor [EPC] 40 0.0005
2 Hedgehog Pathway Inhibitor [EPC] 3 0.0003
3 Peroxisome Proliferator Receptor alpha Agonist [EPC] 14 0.0002
4 Alkylating Drug [EPC] 50 0.0002
5 Vascular Endothelial Growth Factor Inhibitor [EPC] 30 0.0002
6 Platinum-based Drug [EPC] 44 0.0002
7 Cannabinoid [EPC] 1 0.0001
8 Lipid-based Polyene Antifungal [EPC] 1 0.0001
9 Folate Analog Metabolic Inhibitor [EPC] 34 0.0001
10 Melatonin Receptor Agonist [EPC] 1 0.0001
11 Anticholinergic [EPC] 1 0.0001
12 Serotonin-3 Receptor Antagonist [EPC] 8 0.0001
13 Nucleoside Metabolic Inhibitor [EPC] 11 0.0000
14 Provitamin D2 Compound [EPC] 1 0.0000
15 Polyene Antifungal [EPC] 1 0.0000
16 Azole Antifungal [EPC] 2 0.0000
17 Nonsteroidal Anti-inflammatory Drug [EPC] 15 0.0000
18 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
19 Proton Pump Inhibitor [EPC] 6 0.0000
20 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
21 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
22 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
23 alpha-Adrenergic Blocker [EPC] 1 0.0000
24 Leukocyte Growth Factor [EPC] 1 0.0000
25 Estrogen [EPC] 1 0.0000
26 Mood Stabilizer [EPC] 1 0.0000
27 Osmotic Laxative [EPC] 1 0.0000
28 beta-Adrenergic Blocker [EPC] 1 0.0000
29 Corticosteroid [EPC] 4 0.0000
30 Benzodiazepine [EPC] 2 0.0000
31 Loop Diuretic [EPC] 1 0.0000